Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, sparking a warning from experts for regular GP check-ups. Patients on GLP-1 ... — Use of ritonavir-boosted darunavir (Prezista, Tibotec Therapeutics) has been linked to cases of hepatitis in clinical trials and postmarketing experience, the US Food and Drug ...
WHO has released the Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030, a landmark roadmap to address the growing threat of drug resistance and safeguard progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C and sexually transmitted infections (STIs) as public health concerns. WHO launches new framework to tackle drug resistance to HIV, hepatitis ... Liver inflammation, or hepatitis, can be caused by viruses, alcohol, or fatty liver disease. If untreated, liver inflammation can lead to cirrhosis, liver failure, and liver cancer.
drug induced hepatitis, Treatments include ... The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ... About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers ...
drug induced hepatitis, The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.